Project Grant K24AR085177
Award Date
1/20/25
Completion Date
12/31/29
Dollars Obligated
$213K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98101, USA
Similar Awards
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) has awarded a $140,099 K24 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to Duke University. The grant, effective July 20, 2024 through June 30, 2029, aims to enhance the scientific rigor of research and expand the workforce of clinician-scientists in reproductive rheumatology through mentoring and hands-on research. The key products and services to be delivered...
This $206,016 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to advance research on chronic lung disease in children with systemic juvenile idiopathic arthritis (SJIA-LD). The key objectives are to: Define the clinical characteristics and progression of SJIA-LD through a prospective cohort study, leading to a data-derived expert consensus case...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded The Medical University of South Carolina (MUSC) a $365,420 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to study the role of the SLE causal variant NCF1.PR90H in promoting kidney damage. The 2-year project aims to investigate how this genetic variant impacts the function of the NADPH oxidase complex and contributes to systemic lupus erythematosus...
The University of Colorado-Denver received a $367,900 Project Grant (R21AR082655) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant will fund research to develop novel formulations of the drug imatinib that can enhance its delivery and accumulation in the kidney to improve treatment of glomerular kidney diseases, including lupus nephritis. The research team will...
This federal Project Grant award R01AR084694, totaling $788,508.00, was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award supports research to understand the mechanisms linking cutaneous photosensitivity and systemic autoimmunity in systemic lupus erythematosus (SLE), with a focus on the role of Langerhans cells and dermal lymphatic regulation. Key...
The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $163,514 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to Brigham & Women's Hospital Inc. in Boston, MA. The grant, awarded on July 1, 2024, supports research to biochemically define a new G protein-coupled receptor (GPCR) signaling pathway with relevance to chemokine signaling and T cell function. The principal investigator, with mentorship...
This $194,700 federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA 93.846 will support research by Boston Children's Hospital to characterize the biological basis and behavioral outcomes of cognitive dysfunction in childhood-onset systemic lupus erythematosus (cSLE). The 2-year study aims to investigate functional brain properties, white matter microstructure, and choroid plexus volume associated with cognitive...
This federal Project Grant award, valued at $176,148 and funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support a 5-year research and career development plan for Dr. Maxime Kinet at the University of California, San Francisco (UCSF). The overarching goal is to help Dr. Kinet transition to an independently funded physician-scientist studying the role of...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to develop a novel therapeutic approach for treating systemic lupus erythematosus (SLE). The $115,414 award to the Beckman Research Institute of the City of Hope will fund research to determine if knockdown of the long isoform of the prolactin receptor (LFPRLR) can eradicate pathogenic plasma...
This federal Project Grant award of $173,556.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to delineate the role of retroelements (genetic elements derived from viruses) in the pathogenesis of systemic lupus erythematosus (SLE), a serious autoimmune disease. The key objectives are to: 1) characterize gene, retroelement, and inflammatory cytokine...